Association of cardiac and non-cardiac chronic disease comorbidity on glycaemic control in a multi-ethnic population with type 1 and type 2 diabetes

Postgraduate Medical Journal

Volumn 87, Issue 1033, 2011, Pages 763-768

  Mehta, R L ^a   Davies, M J ^b   Ali, S ^c   Taub, N A ^a   Stone, M A ^a   Baker, R ^a   Mcnally, P G ^d   Lawrence, G ^d   Khunti, K ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; HEMOGLOBIN A1C;

ADULT; ARTICLE; ASIAN; CAUCASIAN; CEREBROVASCULAR DISEASE; CHRONIC DISEASE; CHRONIC LOWER RESPIRATORY DISEASE; COLITIS; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; ENTERITIS; ENTEROPATHY; ETHNIC DIFFERENCE; ETHNICITY; FEMALE; GLYCEMIC CONTROL; HEART DISEASE; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL SPECIALIST; MENTAL DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; QUANTITATIVE ANALYSIS; RESPIRATORY TRACT DISEASE; SOFT TISSUE DISEASE; THYROID DISEASE; UNITED KINGDOM;

ADULT; AGE FACTORS; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GREAT BRITAIN; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 80455173894     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/postgradmedj-2011-130298     Document Type: Article

References (42)

1. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53.
2. Murry CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997;349:1269-76.
3. Thomas RJ, Palumbo PJ, Melton LJ 3rd, et al. Trends in the mortality burden associated with diabetes mellitus: a population-based study in Rochester, Minn, 1970-1994. Arch Intern Med 2003;163:445-51.
4. Booth GL, Fung K, Kapral MK, et al. Recent trends in cardiovascular complications among men and women with and without diabetes. Diabetes Care 2006;29:32-7.
5. Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care 1998;21:1138-45.
6. Haffner SM, Letho S, Rönnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34.
7. Anon. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl JMed 1993;14:977-86.
8. Holman RR, Paul SK, Bethel MA, et al. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med 2008;359:1565-76.
9. Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577-89.
10. Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-53.
11. Genuth S, Eastman R, Kahn R, et al. Implications of the United Kingdom prospective diabetes study. Diabetes Care 2003;26(Suppl 1):S28-32.
12. Booth GL, Kapral MK, Fung K, et al. Relationship between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet 2006;368:29-36.
13. Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995;18:258-68.
14. Saremi A, Nelson RG, Tulloch-Reid M, et al. Periodontal disease and mortality in type 2 diabetes. Diabetes Care 2005;28:27-32.
15. Anderson RJ, Freedland KE, Clouse RE, et al. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001;24:1069-78.
16. Bottle A, Millett C, Khunti K, et al. Trends in cardiovascular admissions and procedures for people with and without diabetes in England, 1996-2005. Diabetologia 2009;52:74-80.
17. Lipscombe LL, Hux JE. Trends in diabetes prevalence, incidence and mortality in Ontario, Canada 1995e2005: a population-based study. Lancet 2007;369:750-6.
18. Fox CS, Coady S, Sorlie PD, et al. Trends in cardiovascular complications of diabetes. JAMA 2004;292:2495-9.
19. el-Kebbi IM, Ziemer DC, Gallina DL, et al. Diabetes in urban African Americans. XV. Identification of barriers to provider adherence to management protocols. Diabetes Care 1999;22:1617-20.
20. Home PD. Impact of the UKPDSdan overview. Diabet Med 2008;25(Suppl 2):2-8.
21. Patel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-71.
22. Raikou M, Gray A, Briggs A, et al. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. UK Prospective Diabetes Study Group. BMJ 1998;317:720-6.
23. Rankin J, Bhopal R. Understanding of heart disease and diabetes in a South Asian community: cross-sectional study testing the 'snowball' sample method. Public Health 2001;115:253-60.
24. Anand SS, Yusuf S, Vuksan V, et al. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet 2000;356:279-84.
25. Mather HM, Keen H. The Southall Diabetes Survey: prevalence of known diabetes in Asians and Europeans. Br Med J (Clin Res Ed) 1985;291:1081-4.
26. Khunti K, Ganguli S. Who looks after people with diabetes: primary or secondary care? J R Soc Med 2000;19:183-6.
27. Office for National Statistics. Census Profiles. http://www.statistics.gov.uk/ census2001/profiles/00fn.asp (accessed Jan 2010)
28. Ali S, Davies MJ, Taub NA, et al. Prevalence of diagnosed depression in South Asian and White European people with type 1 and type 2 diabetes mellitus in a UK secondary care population. Postgrad Med J 2009;85:238-43.
29. Noble M, Wright G, Dibben C, et al. The English Indices of Deprivation 2004 (Revised). London: Office of the Deputy Prime Minister, 2005
30. Cummins C, Winter H, Cheng KK, et al. An assessment of the Nam Pehchan computer program for the identification of names of South Asian origin. J Public Health Med 1999;21:401-6.
31. Macfarane GJ, Lunt M, Palmer B, et al. Determining aspects of ethnicity amongst persons of South Asian origin: the use of a surname-classification programme (Nam Pehchan). Public Health 2007;121:231-6.
32. Nicoll A, Bassett K, Ulijaszek SJ. What's in a name? Accuracy of using surnames and forenames in ascribing Asian ethnic identity in English populations. J Epidemiol Community Health 1986;40:364-8.
33. Shapiro SS, Wilk MB. An analysis of variance test for normality (complete samples). Biometrika 1965;52:591-611.
34. Bartlett MS. Properties of sufficiency and statistical tests. Proceedings of the Royal Statistical Society Series A 1937;160:268-82.
35. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2005;28:S4-36.
36. Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd edn. New York, NY: Wiley, 2000
37. Mather HM, Chaturvedi N, Fuller JH. Mortality and morbidity from diabetes in South Asians and Europeans: 11-year follow-up of the Southall Diabetes Survey, London, UK. Diabet Med 1998;15:53-9.
38. Chowdhury TA, Lasker SS. Complications and cardiovascular risk factors in South Asians and Europeans with early-onset type 2 diabetes. QJM 2002;95:241-6.
39. Turner RC, Millns H, Neil HAW, et al. Risk factors for coronary artery disease in noninsulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 1998;316:823-8.
40. Palumbo F, Bianchi C, Miccoli R, et al. Hyperglycaemia and cardiovascular risk. Acta Diabetologica 2003;40:S362-9.
41. Selvin E, Marinopoulos S, Berkenblit G, et al. Meta-analysis: glycosylated haemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004;141:421-31.
42. Sigal RJ. Haemoglobin A1c concentrations were associated with increased cardiovascular disease and all cause mortality. Evid Based Med 2005;10:57